Css LLC Pfizer Inc Transaction History

Css LLC

$902 Million
Q1 2024

A detailed history of Css LLC transactions in Pfizer Inc stock. As of the latest transaction made, Css LLC holds 19,999 shares of PFE stock, worth $559,572. This represents 0.06% of its overall portfolio holdings.

Number of Shares

19,999

Previous 28,999 31.04%

Holding current value

$559,572

Previous $834,000 33.57%

% of portfolio

0.06%

Previous 0.11%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $233,010 - $267,570	-9,000 Reduced 31.04%	19,999 $554,000
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $365,820 - $475,159	-14,000 Reduced 32.56%	28,999 $834,000
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $320,900 - $375,100	10,000 Added 30.3%	42,999 $1.43 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $328,692 - $380,289	9,100 Added 38.08%	32,999 $1.21 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $315,120 - $410,240	8,000 Added 50.32%	23,899 $975,000

Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $236,260 - $288,414	5,399 Added 51.42%	15,899 $696,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $69,795 - $82,755	-1,500 Reduced 12.5%	10,500 $551,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $91,500 - $113,380	2,000 Added 20.0%	12,000 $622,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $330,560 - $490,000	8,000 Added 400.0%	10,000 $590,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $1.92 Million - $2.47 Million	-48,918 Reduced 96.07%	2,000 $86,000
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $1.53 Million - $1.86 Million	50,918 New	50,918 $1.67 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Account